San Diego, CA, United States of America

Armando Tovar

This inventor holds 1 USPTO granted patent. Top assignee: Ortho-Clinical Diagnostics, Inc. Active years: 2026.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Armando Tovar: Innovator in Microfluidic Technology

Introduction

Armando Tovar is a notable inventor based in San Diego, California. He has made significant contributions to the field of microfluidics, particularly through his innovative patent. His work focuses on the development of devices that utilize capillary forces to control liquid movement, which has important applications in diagnostics and research.

Latest Patents

Armando Tovar holds a patent for a microfluidic device and method. This invention involves a combination of components within a capillary flow channel that passively controls the movement of liquid samples. The device allows a liquid sample introduced to a proximal portion of the capillary channel to move by capillary action along specific components, enabling the detection of targets effectively.

Career Highlights

Tovar is currently employed at Ortho-Clinical Diagnostics, Inc., where he continues to advance his research and development in microfluidic technologies. His work is instrumental in enhancing diagnostic capabilities and improving the efficiency of liquid sample analysis.

Collaborations

Armando collaborates with talented individuals in his field, including coworkers Matthew Wang and Erik Mikael Olsson. Their combined expertise contributes to the innovative projects at Ortho-Clinical Diagnostics, Inc.

Conclusion

Armando Tovar's contributions to microfluidic technology exemplify the impact of innovative thinking in the medical diagnostics field. His patent and ongoing work continue to pave the way for advancements in liquid sample analysis.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…